Millan, Mark J.

Descending control of pain

Millan, M. J. (2002) · Progress in Neurobiology

Pain Mechanisms and TreatmentsNeuroscience and Neuropharmacology Research

Cited by 3,035

The induction of pain: an integrative review

Millan, M. J. (1999) · Progress in Neurobiology

Pain Mechanisms and TreatmentsPain Management and Treatment

Cited by 1,774

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery

Schizophrenia research and treatmentDementia and Cognitive Impairment Research

Cited by 1,292

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing

Cunnane, S. C., Trushina, E., Morland, C., Prigione, A., Casadesus, G., Andrews, Z. B., Beal, M. F., Bergersen, L. H., Brinton, R. D., de la Monte, S., et al. (2020) · Nature Reviews Drug Discovery

Mitochondrial Function and PathologyAlzheimer's disease research and treatments

Cited by 1,003

Altering the course of schizophrenia: progress and perspectives

Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., et al. (2016) · Nature Reviews Drug Discovery

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 516

Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention

Fusar-Poli, P., Salazar de Pablo, G., Correll, C. U., Meyer-Lindenberg, A., Millan, M. J., Borgwardt, S., Galderisi, S., Bechdolf, A., Pfennig, A., Kessing, L. V., et al. (2020) · JAMA Psychiatry

Schizophrenia research and treatmentPsychopathy, Forensic Psychiatry, Sexual Offending

Cited by 476

An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy

Millan, M. J. (2013) · Neuropharmacology

Genetics and Neurodevelopmental DisordersEpigenetics and DNA Methylation

Cited by 229

Agomelatine: Mechanism of action and pharmacological profile in relation to antidepressant properties

Guardiola‐Lemaitre, B., De Bodinat, C., Delagrange, P., Millan, M. J., Munoz, C., & Mocaër, E. (2014) · British Journal of Pharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 182

Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling

Cavalleri, L., Merlo Pich, E., Millan, M. J., Chiamulera, C., Kunath, T., Spano, P. F., & Collo, G. (2018) · Molecular Psychiatry

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 156

Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex

Watson, D. J., Loiseau, F., Ingallinesi, M., Millan, M. J., Marsden, C. A., & Fone, K. C. (2012) · Neuropsychopharmacology

Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

Cited by 151

Learning from the past and looking to the future: emerging perspectives for improving the treatment of psychiatric disorders

Millan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 132

Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

Bespalov, A., Steckler, T., Altevogt, B., Koustova, E., Skolnick, P., Deaver, D., Millan, M. J., Bastlund, J. F., Doller, D., Witkin, J., et al. (2016) · Nature Reviews Drug Discovery

Animal testing and alternativesComputational Drug Discovery Methods

Cited by 84